Profiles

Keywords
Last Name
Institution

Connection

Annabelle Volgman to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Annabelle Volgman has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.

 
Connection Strength
 
 
 
1.282
 
  1. Volgman AS, Dembowski E, Braun LT. Should Sex Matter When it Comes to High-Intensity Statins? J Am Coll Cardiol. 2018 04 24; 71(16):1738-1740.
    View in: PubMed
    Score: 0.670
  2. Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008 Mar; 5(1):53-61.
    View in: PubMed
    Score: 0.332
  3. Camara Planek MI, Silver AJ, Volgman AS, Okwuosa TM. Exploratory Review of the Role of Statins, Colchicine, and Aspirin for the Prevention of Radiation-Associated Cardiovascular Disease and Mortality. J Am Heart Assoc. 2020 01 21; 9(2):e014668.
    View in: PubMed
    Score: 0.189
  4. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: Greater risk, less attention. Gend Med. 2009 Sep; 6(3):419-32.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.